ToxoTech is a research development biopharmaceutical company that uses expert knowledge in structural biology to design and develop novel toxin-based biological products for the treatment of neuromuscular and neurological disorders.
TECHNOLOGY PLATFORM
The botulinum neurotoxins are clinically proven molecules that have been used for decades to treat an increasing range of medical conditions. ToxoTech developed a unique, patented technology based on a modified botulinum neurotoxin with enhanced receptor interactions that displays improved pharmacological properties.
OUR VISION
Power with precision: delivering the next generation of enhanced botulinum neurotoxin therapies for neurological wellness.
OUR MISSION
Driven by a commitment to innovation and patient care, we will transform the treatment of neurological disorders with enhanced botulinum neurotoxin therapeutics. We strive to improve patient outcomes and enhance quality of life, all while adhering to the highest standards of ethics, sustainability, and scientific excellence.
Member of the DRIVE Incubator
Copyright © All Rights Reserved
